Mark A Edgar1, Marc K Rosenblum. 1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA. edgarm@mskcc.org
Abstract
CONTEXT: Several distinctive mixed glioneuronal tumors that warrant recognition as clinicopathologic entities have been recently described by neuropathologists. OBJECTIVE: To summarize important clinical, radiologic, and pathologic findings for 3 novel glioneuronal tumors (papillary glioneuronal tumor, rosetted glioneuronal tumor, and rosette-forming glioneuronal tumor of the fourth ventricle). DATA SOURCES: Recent reports in the pathology literature and the authors' experience with mixed glioneuronal tumors at a major cancer center. CONCLUSIONS: Histologic features enabling recognition of these recently described glioneuronal tumors are presented along with remarks concerning the classification of mixed neuronal and glial tumors exhibiting unconventional appearances.
CONTEXT: Several distinctive mixed glioneuronal tumors that warrant recognition as clinicopathologic entities have been recently described by neuropathologists. OBJECTIVE: To summarize important clinical, radiologic, and pathologic findings for 3 novel glioneuronal tumors (papillary glioneuronal tumor, rosetted glioneuronal tumor, and rosette-forming glioneuronal tumor of the fourth ventricle). DATA SOURCES: Recent reports in the pathology literature and the authors' experience with mixed glioneuronal tumors at a major cancer center. CONCLUSIONS: Histologic features enabling recognition of these recently described glioneuronal tumors are presented along with remarks concerning the classification of mixed neuronal and glial tumors exhibiting unconventional appearances.
Authors: S Chakraborti; A Mahadevan; A Govindan; A Bhateja; S Dwarakanath; H R Aravinda; A A Phalguni; V Santosh; T C Yasha; P Rout; S Sampath; S K Shankar Journal: Virchows Arch Date: 2012-09-13 Impact factor: 4.064
Authors: Dara L Aisner; Kathy L Newell; Ania G Pollack; Bette K Kleinschmidt-Demasters; Gary K Steinberg; Lawrence T Smyth; Hannes Vogel Journal: Clin Neuropathol Date: 2014 Mar-Apr Impact factor: 1.368